Date of Report (Date of earliest event reported) ____________________________ | |||||||||||
(Exact name of Registrant as Specified in its Charter) ____________________________ | |||||||||||
(State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | |||||||||
(Address of Principal Executive Offices) | (Zip Code) |
(Registrant's Telephone Number, Including Area Code) | |||||||||||
N/A (Former name or former address, if changed since last report.) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on which Registered | |||||||||
par value $0.01 per share |
(d) | Exhibits |
Exhibit No. | Description | |||||||
Aramark | ||||||||||||||
Date: | By: | /s/ THOMAS G. ONDROF | ||||||||||||
Name: | THOMAS G. ONDROF | |||||||||||||
Title: | Executive Vice President and | |||||||||||||
Chief Financial Officer |
Exhibit No. | Description | |||||||
For Immediate Release | Contact: | |||||||
Investor Inquiries: Felise Kissell (215) 409-7287 Kissell-Felise@aramark.com | Media Inquiries: Karen Cutler (215) 238-4063 Cutler-Karen@aramark.com |
Q3 '20 Change (%) | Q4 '20 Change (%) | Q3 '20 Organic Revenue Change (%) | Q4 '20 Organic Revenue Change (%) | ||||||||||||||
FSS United States | (56)% | (41)% | (56)% | (45)% | |||||||||||||
FSS International | (46)% | (30)% | (41)% | (31)% | |||||||||||||
Uniform & Career Apparel | (12)% | (2)% | (12)% | (9)% | |||||||||||||
Total Company | (46)% | (32)% | (45)% | (36)% |
Sector | Q4 Activity | ||||
Education | Served approximately 90% of Higher Ed client locations in some manner, while experiencing lower retail and catering volumes. Actively participated in universal government-sponsored meal programs in K-12. | ||||
Sports, Leisure & Corrections | Stadium attendance remained limited as leagues included fans based on local jurisdiction. Leisure reflected increased activity with modified operations. Corrections remained stable. | ||||
Business & Industry | Companies remained measured in return-to-work practices with reduced operations as decisions were driven largely by need and corporate culture as well as local regulatory restrictions. | ||||
Healthcare | Signs of strengthened performance as elective procedures increased and visitor restrictions began to ease in the quarter. | ||||
Facilities & Other | Provided more frequent and comprehensive services as client locations carefully reopened. |
Revenue | ||||||||||||||||||||
Q4 '20 | Q4 '19 | Change ($) | Change (%) | Organic Revenue Change ($) | Organic Revenue Change (%) | |||||||||||||||
FSS United States | $1,429M | $2,408M | ($979M) | (41)% | ($1,095M) | (45)% | ||||||||||||||
FSS International | 629 | 898 | (269) | (30)% | (280) | (31)% | ||||||||||||||
Uniform & Career Apparel | 634 | 646 | (11) | (2)% | (56) | (9)% | ||||||||||||||
Total Company | $2,692M | $3,951M | ($1,259M) | (32)% | ($1,431M) | (36)% |
Operating (Loss) Income | Adjusted Operating (Loss) Income | ||||||||||||||||||||||||||||
Q4 '20 | Q4 '19 | Change (%) | Q4 '20 | Q4 '19 | Change ($) | Constant Currency Change ($) | Constant-Currency Change (%) | ||||||||||||||||||||||
FSS United States | ($53M) | $156M | (134)% | ($6M) | $205M | ($211M) | ($211M) | (103)% | |||||||||||||||||||||
FSS International | (58) | 49 | (219)% | (30) | 56 | (86) | (86) | (154)% | |||||||||||||||||||||
Uniform & Career Apparel | 50 | 47 | 6% | 57 | 71 | (14) | (15) | (20)% | |||||||||||||||||||||
Corporate | (32) | (46) | 30% | (33) | (13) | (20) | (20) | (162%) | |||||||||||||||||||||
Total Company | ($94M) | $206M | (146)% | ($12M) | $320M | ($331M) | ($332M) | (104)% | |||||||||||||||||||||
Forward-Looking Statements | ||
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect our current expectations as to future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. For example, statements regarding the potential future impact of the COVID-19 pandemic on our business, financial performance and operating results are forward-looking statements. These statements also include, but are not limited to, statements related to our expectations regarding performance of our business, our financial results, our operations, conditions in our industry and our business and growth strategy. Forward-looking statements can also be identified by words such as "outlook," "aim," "anticipate," "are or remain or continue to be confident," "have confidence," "estimate," "expect," "will be," "will continue," "will likely result," "project," "intend," "plan," "believe," "see," "look to" and other words and terms of similar meaning or the negative versions of such words. | ||
Forward-looking statements speak only as of the date made. These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected. We derive many of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and, of course, it is impossible for us to anticipate all factors that could affect our actual results. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements. | ||
Some of the factors that we believe could affect or continue to affect our results or the costs and benefits of the acquisitions include without limitation: the severity and duration of the COVID-19 pandemic; the pandemic's impact on the U.S. and global economies, including particularly the client sectors we serve, and governmental responses to the pandemic; unfavorable economic conditions; natural disasters, global calamities, new pandemics, sports strikes and other adverse incidents; the failure to retain current clients, renew existing client contracts and obtain new client contracts; the manner and timing of benefits we expect to receive under the CARES Act or other government programs; a determination by clients to reduce their outsourcing or use of preferred vendors; competition in our industries; increased operating costs and obstacles to cost recovery due to the pricing and cancellation terms of our food and support services contracts; our expansion strategy; our ability to successfully integrate the businesses we acquire and costs and timing related thereto; the risk of unanticipated restructuring costs or assumption of undisclosed liabilities; the risk that we are unable to achieve the anticipated benefits (including tax benefits) and synergies of acquisitions, including whether such transactions will be accretive and within the expected timeframes; the availability of sufficient cash to repay certain indebtedness and our decision to utilize the cash for that purpose; the failure to maintain food safety throughout our supply chain, food-borne illness concerns and claims of illness or injury; governmental regulations including those relating to food and beverages, the environment, wage and hour and government contracting; liability associated with noncompliance with applicable law or other governmental regulations; new interpretations of or changes in the enforcement of the government regulatory framework; currency risks and other risks associated with international operations, including Foreign Corrupt Practices Act, U.K. Bribery Act and other anti-corruption law compliance; continued or further unionization of our workforce; liability resulting from our participation in multiemployer defined benefit pension plans; risks associated with suppliers from whom our products are sourced; disruptions to our relationship with, or to the business of, our primary distributor and other distribution partners; the inability to hire and retain sufficient qualified personnel or increases in labor costs; healthcare reform legislation; the contract intensive nature of our business, which may lead to client disputes; seasonality; a cybersecurity incident or other disruptions in the availability of our computer systems or privacy breaches; our leverage, including our recent significantly increased borrowings; the inability to generate sufficient cash to service all of our indebtedness; debt agreements that limit our flexibility in operating our business; our ability to attract new or maintain existing customer and supplier relationships at reasonable cost; our ability to retain key personnel and other factors set forth in our Quarterly Report on Form 10-Q filed with the SEC on August 4, 2020 under the headings “Risk Factors” and “Management Discussion and Analysis of Financial Condition and Results of Operations” and under the headings Item 1A "Risk Factors," Item 3 "Legal Proceedings" and Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" and other sections of our Annual Report on Form 10-K, filed with the SEC on November 26, 2019 as such factors may be updated from time to time in our other periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov and which may be obtained by contacting Aramark's investor relations department via its website www.aramark.com. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in our other filings with the SEC. As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements included herein or that may be made elsewhere from time to time by, or on behalf of, us. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, changes in our expectations, or otherwise, except as required by law. |
Three Months Ended | ||||||||||||||
October 2, 2020 | September 27, 2019 | |||||||||||||
Revenue | $ | 2,692,150 | $ | 3,951,244 | ||||||||||
Costs and Expenses: | ||||||||||||||
Cost of services provided | 2,552,351 | 3,503,280 | ||||||||||||
Depreciation and amortization | 151,224 | 145,165 | ||||||||||||
Selling and general corporate expenses | 82,514 | 96,656 | ||||||||||||
2,786,089 | 3,745,101 | |||||||||||||
Operating (loss) income | (93,939) | 206,143 | ||||||||||||
Interest and Other Financing Costs, net | 109,158 | 85,612 | ||||||||||||
(Loss) Income Before Income Taxes | (203,097) | 120,531 | ||||||||||||
(Benefit) Provision for Income Taxes | (54,108) | 35,117 | ||||||||||||
Net (loss) income | (148,989) | 85,414 | ||||||||||||
Less: Net loss attributable to noncontrolling interest | (399) | (143) | ||||||||||||
Net (loss) income attributable to Aramark stockholders | $ | (148,590) | $ | 85,557 | ||||||||||
(Loss) Earnings per share attributable to Aramark stockholders: | ||||||||||||||
Basic | $ | (0.59) | $ | 0.35 | ||||||||||
Diluted | $ | (0.59) | $ | 0.34 | ||||||||||
Weighted Average Shares Outstanding: | ||||||||||||||
Basic | 253,178 | 247,431 | ||||||||||||
Diluted | 253,178 | 253,404 | ||||||||||||
Fiscal Year Ended | ||||||||||||||
October 2, 2020 | September 27, 2019 | |||||||||||||
Revenue | $ | 12,829,559 | $ | 16,227,341 | ||||||||||
Costs and Expenses: | ||||||||||||||
Cost of services provided | 11,993,667 | 14,532,662 | ||||||||||||
Depreciation and amortization | 595,195 | 592,573 | ||||||||||||
Selling and general corporate expenses | 307,016 | 367,256 | ||||||||||||
Goodwill impairment | 198,600 | — | ||||||||||||
Gain on sale of Healthcare Technologies | — | (156,309) | ||||||||||||
13,094,478 | 15,336,182 | |||||||||||||
Operating (loss) income | (264,919) | 891,159 | ||||||||||||
Interest and Other Financing Costs, net | 382,800 | 334,987 | ||||||||||||
(Loss) Income Before Income Taxes | (647,719) | 556,172 | ||||||||||||
(Benefit) Provision for Income Taxes | (186,284) | 107,706 | ||||||||||||
Net (loss) income | (461,435) | 448,466 | ||||||||||||
Less: Net income (loss) attributable to noncontrolling interest | 94 | (83) | ||||||||||||
Net (loss) income attributable to Aramark stockholders | $ | (461,529) | $ | 448,549 | ||||||||||
(Loss) Earnings per share attributable to Aramark stockholders: | ||||||||||||||
Basic | $ | (1.83) | $ | 1.82 | ||||||||||
Diluted | $ | (1.83) | $ | 1.78 | ||||||||||
Weighted Average Shares Outstanding: | ||||||||||||||
Basic | 251,828 | 246,854 | ||||||||||||
Diluted | 251,828 | 252,010 |
ARAMARK AND SUBSIDIARIES | ||||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS* | ||||||||||||||
(Unaudited) | ||||||||||||||
(In Thousands) | ||||||||||||||
October 2, 2020 | September 27, 2019 | |||||||||||||
Assets | ||||||||||||||
Current Assets: | ||||||||||||||
Cash and cash equivalents | $ | 2,509,188 | $ | 246,643 | ||||||||||
Receivables | 1,431,206 | 1,806,964 | ||||||||||||
Inventories | 436,473 | 411,319 | ||||||||||||
Prepayments and other current assets | 298,944 | 193,461 | ||||||||||||
Total current assets | 4,675,811 | 2,658,387 | ||||||||||||
Property and Equipment, net | 2,050,908 | 2,181,762 | ||||||||||||
Goodwill | 5,343,828 | 5,518,800 | ||||||||||||
Other Intangible Assets | 1,932,637 | 2,033,566 | ||||||||||||
Operating Lease Right-of-use Assets | 551,394 | — | ||||||||||||
Other Assets | 1,158,106 | 1,343,806 | ||||||||||||
$ | 15,712,684 | $ | 13,736,321 | |||||||||||
Liabilities and Stockholders' Equity | ||||||||||||||
Current Liabilities: | ||||||||||||||
Current maturities of long-term borrowings | $ | 99,915 | $ | 69,928 | ||||||||||
Current operating lease liabilities | 71,810 | — | ||||||||||||
Accounts payable | 663,455 | 999,517 | ||||||||||||
Accrued expenses and other current liabilities | 1,512,278 | 1,635,853 | ||||||||||||
Total current liabilities | 2,347,458 | 2,705,298 | ||||||||||||
Long-Term Borrowings | 9,178,508 | 6,612,239 | ||||||||||||
Noncurrent Operating Lease Liabilities | 341,667 | — | ||||||||||||
Deferred Income Taxes and Other Noncurrent Liabilities | 1,099,075 | 1,088,822 | ||||||||||||
Redeemable Noncontrolling Interest | 9,988 | 9,915 | ||||||||||||
Total Stockholders' Equity | 2,735,988 | 3,320,047 | ||||||||||||
$ | 15,712,684 | $ | 13,736,321 | |||||||||||
*In connection with the Company's adoption of ASC 842, Leases, three new line items were added to the balance sheet to reflect the recording of operating lease liabilities (current and noncurrent), offset by operating lease right-of-use assets. Further details will be available in the Annual Report on Form 10-K for the fiscal year ended October 2, 2020. |
ARAMARK AND SUBSIDIARIES | ||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||||||
(Unaudited) | ||||||||||||||
(In Thousands) | ||||||||||||||
Fiscal Year Ended | ||||||||||||||
October 2, 2020 | September 27, 2019 | |||||||||||||
Cash flows from operating activities: | ||||||||||||||
Net (loss) income | $ | (461,435) | $ | 448,466 | ||||||||||
Adjustments to reconcile net (loss) income to net cash provided by operating activities | ||||||||||||||
Depreciation and amortization | 595,195 | 592,573 | ||||||||||||
Goodwill impairment and asset write-downs | 283,743 | — | ||||||||||||
Deferred income taxes | (134,048) | 40,503 | ||||||||||||
Share-based compensation expense | 30,339 | 55,280 | ||||||||||||
Net gain on sale of Healthcare Technologies | — | (139,165) | ||||||||||||
Changes in operating assets and liabilities | (235,120) | 44,855 | ||||||||||||
Payments made to clients on contracts | (69,575) | (40,073) | ||||||||||||
Other operating activities | 167,583 | (18,212) | ||||||||||||
Net cash provided by operating activities | 176,682 | 984,227 | ||||||||||||
Cash flows from investing activities: | ||||||||||||||
Net purchases of property and equipment and other | (364,434) | (485,219) | ||||||||||||
Acquisitions, divestitures and other investing activities | 3,314 | 275,698 | ||||||||||||
Net cash used in investing activities | (361,120) | (209,521) | ||||||||||||
Cash flows from financing activities: | ||||||||||||||
Net proceeds/payments of long-term borrowings | 2,239,309 | (576,930) | ||||||||||||
Net change in funding under the Receivables Facility | 315,600 | — | ||||||||||||
Payments of dividends | (110,893) | (108,439) | ||||||||||||
Proceeds from issuance of common stock | 90,022 | 39,087 | ||||||||||||
Repurchase of stock | (6,540) | (50,000) | ||||||||||||
Other financing activities | (89,976) | (38,610) | ||||||||||||
Net cash provided by (used in) financing activities | 2,437,522 | (734,892) | ||||||||||||
Effect of foreign exchange rates on cash and cash equivalents | 9,461 | (8,196) | ||||||||||||
Increase in cash and cash equivalents | 2,262,545 | 31,618 | ||||||||||||
Cash and cash equivalents, beginning of period | 246,643 | 215,025 | ||||||||||||
Cash and cash equivalents, end of period | $ | 2,509,188 | $ | 246,643 |
ARAMARK AND SUBSIDIARIES | ||||||||||||||||||||||||||||||||
RECONCILIATION OF NON-GAAP MEASURES | ||||||||||||||||||||||||||||||||
ADJUSTED CONSOLIDATED OPERATING (LOSS) INCOME MARGIN | ||||||||||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||||||||||||||
October 2, 2020 | ||||||||||||||||||||||||||||||||
FSS United States | FSS International | Uniform | Corporate | Aramark and Subsidiaries | ||||||||||||||||||||||||||||
Revenue (as reported) | $ | 1,429,031 | $ | 629,021 | $ | 634,098 | $ | 2,692,150 | ||||||||||||||||||||||||
Operating (Loss) Income (as reported) | $ | (52,634) | $ | (58,488) | $ | 49,569 | $ | (32,386) | $ | (93,939) | ||||||||||||||||||||||
Operating (Loss) Income Margin (as reported) | (3.68) | % | (9.30) | % | 7.82 | % | (3.49) | % | ||||||||||||||||||||||||
Revenue (as reported) | $ | 1,429,031 | $ | 629,021 | $ | 634,098 | $ | 2,692,150 | ||||||||||||||||||||||||
Effect of Currency Translation | 185 | 4,785 | 454 | 5,424 | ||||||||||||||||||||||||||||
Estimated Impact of 53rd Week | (116,461) | (15,858) | (44,740) | (177,059) | ||||||||||||||||||||||||||||
Adjusted Revenue (Organic) | $ | 1,312,755 | $ | 617,948 | $ | 589,812 | $ | 2,520,515 | ||||||||||||||||||||||||
Revenue Growth (as reported) | (40.65) | % | (29.94) | % | (1.78) | % | (31.87) | % | ||||||||||||||||||||||||
Adjusted Revenue Growth (Organic) | (45.48) | % | (31.18) | % | (8.64) | % | (36.21) | % | ||||||||||||||||||||||||
Operating (Loss) Income (as reported) | $ | (52,634) | $ | (58,488) | $ | 49,569 | $ | (32,386) | $ | (93,939) | ||||||||||||||||||||||
Amortization of Acquisition-Related Intangible Assets | 21,101 | 1,824 | 6,235 | — | 29,160 | |||||||||||||||||||||||||||
Severance and Other Charges | 3,571 | 12,594 | 4,556 | 169 | 20,890 | |||||||||||||||||||||||||||
Merger and Integration Related Charges | 111 | 176 | 6,176 | — | 6,463 | |||||||||||||||||||||||||||
Estimated Impact of 53rd Week | (825) | 827 | (2,885) | 2,520 | (363) | |||||||||||||||||||||||||||
Gains, Losses and Settlements impacting comparability | 22,575 | 13,342 | (6,673) | (3,088) | 26,156 | |||||||||||||||||||||||||||
Adjusted Operating (Loss) Income | $ | (6,101) | $ | (29,725) | $ | 56,978 | $ | (32,785) | $ | (11,633) | ||||||||||||||||||||||
Effect of Currency Translation | 99 | (348) | (82) | — | (331) | |||||||||||||||||||||||||||
Adjusted Operating (Loss) Income (Constant Currency) | $ | (6,002) | $ | (30,073) | $ | 56,896 | $ | (32,785) | $ | (11,964) | ||||||||||||||||||||||
Operating (Loss) Income Growth (as reported) | (133.68) | % | (218.86) | % | 5.82 | % | 29.90 | % | (145.57) | % | ||||||||||||||||||||||
Adjusted Operating (Loss) Income Growth | (102.98) | % | (153.14) | % | (20.23) | % | (162.28) | % | (103.64) | % | ||||||||||||||||||||||
Adjusted Operating (Loss) Income Growth (Constant Currency) | (102.93) | % | (153.76) | % | (20.35) | % | (162.28) | % | (103.74) | % | ||||||||||||||||||||||
Adjusted Operating (Loss) Income Margin (Constant Currency) | (0.46) | % | (4.87) | % | 9.65 | % | (0.47) | % | ||||||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||||||||||||||
September 27, 2019 | ||||||||||||||||||||||||||||||||
FSS United States | FSS International | Uniform | Corporate | Aramark and Subsidiaries | ||||||||||||||||||||||||||||
Revenue (as reported) | $ | 2,407,750 | $ | 897,894 | $ | 645,600 | $ | 3,951,244 | ||||||||||||||||||||||||
Operating Income (as reported) | $ | 156,290 | $ | 49,209 | $ | 46,843 | $ | (46,199) | $ | 206,143 | ||||||||||||||||||||||
Amortization of Acquisition-Related Intangible Assets | 21,209 | 1,952 | 6,148 | — | 29,309 | |||||||||||||||||||||||||||
Severance and Other Charges | (1,393) | (888) | (300) | 13,540 | 10,959 | |||||||||||||||||||||||||||
Merger and Integration Related Charges | 1,014 | — | 8,738 | — | 9,752 | |||||||||||||||||||||||||||
Tax Reform Related Employee Reinvestments | 3,228 | — | 1,144 | — | 4,372 | |||||||||||||||||||||||||||
Advisory Fees Related to Shareholder Matters | — | — | — | 7,661 | 7,661 | |||||||||||||||||||||||||||
Gains, Losses and Settlements impacting comparability | 24,591 | 5,664 | 8,859 | 12,498 | 51,612 | |||||||||||||||||||||||||||
Adjusted Operating Income | $ | 204,939 | $ | 55,937 | $ | 71,432 | $ | (12,500) | $ | 319,808 | ||||||||||||||||||||||
Operating Income Margin (as reported) | 6.49 | % | 5.48 | % | 7.26 | % | 5.22 | % | ||||||||||||||||||||||||
Adjusted Operating Income Margin | 8.51 | % | 6.23 | % | 11.06 | % | 8.09 | % |
ARAMARK AND SUBSIDIARIES | ||||||||||||||||||||||||||||||||
RECONCILIATION OF NON-GAAP MEASURES | ||||||||||||||||||||||||||||||||
ADJUSTED CONSOLIDATED OPERATING (LOSS) INCOME MARGIN | ||||||||||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Fiscal Year Ended | ||||||||||||||||||||||||||||||||
October 2, 2020 | ||||||||||||||||||||||||||||||||
FSS United States | FSS International | Uniform | Corporate | Aramark and Subsidiaries | ||||||||||||||||||||||||||||
Revenue (as reported) | $ | 7,366,678 | $ | 2,945,834 | $ | 2,517,047 | $ | 12,829,559 | ||||||||||||||||||||||||
Operating Income (Loss) (as reported) | $ | 5,312 | $ | (344,274) | $ | 171,525 | $ | (97,482) | $ | (264,919) | ||||||||||||||||||||||
Operating Income (Loss) Margin (as reported) | 0.07 | % | (11.69) | % | 6.81 | % | (2.06) | % | ||||||||||||||||||||||||
Revenue (as reported) | $ | 7,366,678 | $ | 2,945,834 | $ | 2,517,047 | $ | 12,829,559 | ||||||||||||||||||||||||
Effect of Currency Translation | 836 | 132,602 | 2,135 | 135,573 | ||||||||||||||||||||||||||||
Estimated Impact of 53rd Week | (116,461) | (15,858) | (44,740) | (177,059) | ||||||||||||||||||||||||||||
Adjusted Revenue (Organic) | $ | 7,251,053 | $ | 3,062,578 | $ | 2,474,442 | $ | 12,788,073 | ||||||||||||||||||||||||
Revenue Growth (as reported) | (25.58) | % | (21.30) | % | (2.66) | % | (20.94) | % | ||||||||||||||||||||||||
Adjusted Revenue Growth (Organic) | (26.42) | % | (18.18) | % | (4.31) | % | (20.98) | % | ||||||||||||||||||||||||
Operating Income (Loss) (as reported) | $ | 5,312 | $ | (344,274) | $ | 171,525 | $ | (97,482) | $ | (264,919) | ||||||||||||||||||||||
Amortization of Acquisition-Related Intangible Assets | 84,863 | 6,812 | 24,849 | — | 116,524 | |||||||||||||||||||||||||||
Severance and Other Charges | 51,776 | 90,945 | 4,923 | 5,073 | 152,717 | |||||||||||||||||||||||||||
Merger and Integration Related Charges | 3,591 | 701 | 24,576 | — | 28,868 | |||||||||||||||||||||||||||
Goodwill Impairment | — | 198,600 | — | — | 198,600 | |||||||||||||||||||||||||||
Tax Reform Related Employee Reinvestments | 1,436 | — | (13) | — | 1,423 | |||||||||||||||||||||||||||
Estimated Impact of 53rd Week | (825) | 827 | (2,885) | 2,520 | (363) | |||||||||||||||||||||||||||
Gains, Losses and Settlements impacting comparability | 67,132 | 14,453 | (22,947) | 2,597 | 61,235 | |||||||||||||||||||||||||||
Adjusted Operating Income (Loss) | $ | 213,285 | $ | (31,936) | $ | 200,028 | $ | (87,292) | $ | 294,085 | ||||||||||||||||||||||
Effect of Currency Translation | 173 | (2,940) | (264) | — | (3,031) | |||||||||||||||||||||||||||
Adjusted Operating Income (Loss) (Constant Currency) | $ | 213,458 | $ | (34,876) | $ | 199,764 | $ | (87,292) | $ | 291,054 | ||||||||||||||||||||||
Operating Income (Loss) Growth (as reported) | (99.26) | % | (341.22) | % | (10.36) | % | 38.93 | % | (129.73) | % | ||||||||||||||||||||||
Adjusted Operating Income (Loss) Growth | (71.23) | % | (118.23) | % | (25.58) | % | 12.72 | % | (72.91) | % | ||||||||||||||||||||||
Adjusted Operating Income (Loss) Growth (Constant Currency) | (71.21) | % | (119.90) | % | (25.68) | % | 12.72 | % | (73.19) | % | ||||||||||||||||||||||
Adjusted Operating Income (Loss) Margin (Constant Currency) | 2.94 | % | (1.14) | % | 8.07 | % | 2.28 | % | ||||||||||||||||||||||||
Fiscal Year Ended | ||||||||||||||||||||||||||||||||
September 27, 2019 | ||||||||||||||||||||||||||||||||
FSS United States | FSS International | Uniform | Corporate | Aramark and Subsidiaries | ||||||||||||||||||||||||||||
Revenue (as reported) | $ | 9,898,568 | $ | 3,742,939 | $ | 2,585,834 | $ | 16,227,341 | ||||||||||||||||||||||||
Effect of Divestitures | (43,680) | — | — | (43,680) | ||||||||||||||||||||||||||||
Adjusted Revenue (Organic) | $ | 9,854,888 | $ | 3,742,939 | $ | 2,585,834 | $ | 16,183,661 | ||||||||||||||||||||||||
Operating Income (as reported) | $ | 716,729 | $ | 142,721 | $ | 191,344 | $ | (159,635) | $ | 891,159 | ||||||||||||||||||||||
Amortization of Acquisition-Related Intangible Assets | 86,696 | 5,927 | 24,421 | — | 117,044 | |||||||||||||||||||||||||||
Severance and Other Charges | 13,196 | 17,057 | 193 | 28,001 | 58,447 | |||||||||||||||||||||||||||
Effect of Divestitures | (4,003) | — | — | — | (4,003) | |||||||||||||||||||||||||||
Merger and Integration Related Charges | 6,534 | — | 29,526 | 8 | 36,068 | |||||||||||||||||||||||||||
Gain on Sale of Healthcare Technologies | (156,309) | — | — | — | (156,309) | |||||||||||||||||||||||||||
Tax Reform Related Employee Reinvestments | 58,657 | 352 | 14,442 | 1,443 | 74,894 | |||||||||||||||||||||||||||
Advisory Fees Related to Shareholder Matters | — | — | — | 7,661 | 7,661 | |||||||||||||||||||||||||||
Gains, Losses and Settlements impacting comparability | 19,930 | 9,171 | 8,859 | 22,504 | 60,464 | |||||||||||||||||||||||||||
Adjusted Operating Income | $ | 741,430 | $ | 175,228 | $ | 268,785 | $ | (100,018) | $ | 1,085,425 | ||||||||||||||||||||||
Operating Income Margin (as reported) | 7.24 | % | 3.81 | % | 7.40 | % | 5.49 | % | ||||||||||||||||||||||||
Adjusted Operating Income Margin | 7.52 | % | 4.68 | % | 10.39 | % | 6.71 | % |
ARAMARK AND SUBSIDIARIES | |||||||||||||||||||||||||||||
RECONCILIATION OF NON-GAAP MEASURES | |||||||||||||||||||||||||||||
ADJUSTED NET (LOSS) INCOME & ADJUSTED (LOSS) EARNINGS PER SHARE | |||||||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||||||
(In thousands, except per share amounts) | |||||||||||||||||||||||||||||
Three Months Ended | Fiscal Year Ended | ||||||||||||||||||||||||||||
October 2, 2020 | September 27, 2019 | October 2, 2020 | September 27, 2019 | ||||||||||||||||||||||||||
Net (Loss) Income Attributable to Aramark Stockholders (as reported) | $ | (148,590) | $ | 85,557 | $ | (461,529) | $ | 448,549 | |||||||||||||||||||||
Adjustment: | |||||||||||||||||||||||||||||
Amortization of Acquisition-Related Intangible Assets | 29,160 | 29,309 | 116,524 | 117,044 | |||||||||||||||||||||||||
Severance and Other Charges | 20,890 | 10,959 | 152,717 | 58,447 | |||||||||||||||||||||||||
Effect of Divestitures | — | — | — | (4,003) | |||||||||||||||||||||||||
Merger and Integration Related Charges | 6,463 | 9,752 | 28,868 | 36,068 | |||||||||||||||||||||||||
Goodwill Impairment | — | — | 198,600 | — | |||||||||||||||||||||||||
Gain on sale of Healthcare Technologies | — | — | — | (156,309) | |||||||||||||||||||||||||
Tax Reform Related Employee Reinvestments | — | 4,372 | 1,423 | 74,894 | |||||||||||||||||||||||||
Advisory Fees related to Shareholder Matters | — | 7,661 | — | 7,661 | |||||||||||||||||||||||||
Estimated Impact of 53rd Week | 6,973 | — | 6,973 | — | |||||||||||||||||||||||||
Gains, Losses and Settlements impacting comparability | 26,156 | 51,612 | 61,235 | 60,464 | |||||||||||||||||||||||||
Effects of Refinancing and Other on Interest and Other Financing Costs, net | — | 2,219 | 20,883 | 2,219 | |||||||||||||||||||||||||
Effect of Tax Legislation on (Benefit) Provision for Income Taxes | (11,469) | — | (58,437) | (12,126) | |||||||||||||||||||||||||
Tax Impact Related to Shareholder Transactions | 2,258 | — | (18,221) | — | |||||||||||||||||||||||||
Tax Impact of Adjustments to Adjusted Net (Loss) Income | (21,338) | (28,858) | (90,964) | (72,115) | |||||||||||||||||||||||||
Adjusted Net (Loss) Income | $ | (89,497) | $ | 172,583 | $ | (41,928) | $ | 560,793 | |||||||||||||||||||||
Effect of Currency Translation, net of Tax | (963) | — | (3,758) | — | |||||||||||||||||||||||||
Adjusted Net (Loss) Income (Constant Currency) | $ | (90,460) | $ | 172,583 | $ | (45,686) | $ | 560,793 | |||||||||||||||||||||
(Loss) Earnings Per Share (as reported) | |||||||||||||||||||||||||||||
Net (Loss) Income Attributable to Aramark Stockholders (as reported) | $ | (148,590) | $ | 85,557 | $ | (461,529) | $ | 448,549 | |||||||||||||||||||||
Diluted Weighted Average Shares Outstanding | 253,178 | 253,404 | 251,828 | 252,010 | |||||||||||||||||||||||||
$ | (0.59) | $ | 0.34 | $ | (1.83) | $ | 1.78 | ||||||||||||||||||||||
Adjusted (Loss) Earnings Per Share | |||||||||||||||||||||||||||||
Adjusted Net (Loss) Income | $ | (89,497) | $ | 172,583 | $ | (41,928) | $ | 560,793 | |||||||||||||||||||||
Diluted Weighted Average Shares Outstanding | 253,178 | 253,404 | 251,828 | 252,010 | |||||||||||||||||||||||||
$ | (0.35) | $ | 0.68 | $ | (0.17) | $ | 2.23 | ||||||||||||||||||||||
Adjusted (Loss) Earnings Per Share (Constant Currency) | |||||||||||||||||||||||||||||
Adjusted Net (Loss) Income (Constant Currency) | $ | (90,460) | $ | 172,583 | $ | (45,686) | $ | 560,793 | |||||||||||||||||||||
Diluted Weighted Average Shares Outstanding | 253,178 | 253,404 | 251,828 | 252,010 | |||||||||||||||||||||||||
$ | (0.36) | $ | 0.68 | $ | (0.18) | $ | 2.23 |
ARAMARK AND SUBSIDIARIES | |||||||||||||||||
RECONCILIATION OF NON-GAAP MEASURES | |||||||||||||||||
NET DEBT TO COVENANT ADJUSTED EBITDA | |||||||||||||||||
(Unaudited) | |||||||||||||||||
(In thousands) | |||||||||||||||||
Fiscal Year Ended | |||||||||||||||||
October 2, 2020 | September 27, 2019 | ||||||||||||||||
Net (Loss) Income Attributable to Aramark Stockholders (as reported) | $ | (461,529) | $ | 448,549 | |||||||||||||
Interest and Other Financing Costs, net | 382,800 | 334,987 | |||||||||||||||
(Benefit) Provision for Income Taxes | (186,284) | 107,706 | |||||||||||||||
Depreciation and Amortization | 595,195 | 592,573 | |||||||||||||||
Share-based compensation expense(1) | 30,339 | 55,280 | |||||||||||||||
Unusual or non-recurring losses and (gains)(2) | 198,600 | (156,309) | |||||||||||||||
Pro forma EBITDA for equity method investees(3) | 10,070 | 8,077 | |||||||||||||||
Pro forma EBITDA for certain transactions(4) | 6,300 | 21,527 | |||||||||||||||
Other(5) | 490,573 | 253,480 | |||||||||||||||
Covenant Adjusted EBITDA | $ | 1,066,064 | $ | 1,665,870 | |||||||||||||
Net Debt to Covenant Adjusted EBITDA | |||||||||||||||||
Total Long-Term Borrowings | $ | 9,278,423 | $ | 6,682,167 | |||||||||||||
Less: Cash and cash equivalents | 2,509,188 | 246,643 | |||||||||||||||
Net Debt | $ | 6,769,235 | $ | 6,435,524 | |||||||||||||
Covenant Adjusted EBITDA | $ | 1,066,064 | $ | 1,665,870 | |||||||||||||
Net Debt/Covenant Adjusted EBITDA(6) | 6.3 | 3.9 | |||||||||||||||
(1) Represents compensation expense related to the Company's issuances of share-based awards. | |||||||||||||||||
(2) Represents the fiscal 2020 non-cash impairment charge related to goodwill and the fiscal 2019 gain from the divestiture of HCT. | |||||||||||||||||
(3) Represents our estimated share of EBITDA primarily from our AIM Services Co., Ltd. equity method investment, not already reflected in our net (loss) income attributable to Aramark stockholders. EBITDA for this equity method investee is calculated in a manner consistent with Covenant Adjusted EBITDA but does not represent cash distributions received from this investee. | |||||||||||||||||
(4) Represents the annualizing of net EBITDA from certain acquisitions and divestitures made during the period. | |||||||||||||||||
(5) "Other" for the twelve months ended October 2, 2020 and September 27, 2019, respectively, includes severance charges ($152.7 million and $18.7 million), non-cash impairment charges related to various assets ($30.6 million and $14.8 million), expenses related to merger and integration related charges ($28.9 million and $36.1 million), adjustments to remove the impact attributable to the adoption of certain accounting standards that are made to the calculation in accordance with the Credit Agreement and indentures ($23.1 million and $23.7 million), the impact of hyperinflation in Argentina ($2.5 million and $4.9 million), compensation expense for retirement contributions and employee training programs funded by benefits from U.S. tax reform ($1.4 million and $74.9 million), charges related to certain legal settlements ($1.0 million net expense reduction and $27.9 million), the loss from the change in fair value related to certain gasoline and diesel agreements ($0.5 million and $4.7 million) and other miscellaneous expenses. "Other" for the twelve months ended October 2, 2020 also includes labor charges, incremental expenses and other expenses associated with closed or partially closed client locations resulting from the COVID-19 pandemic, net of U.S. and non-U.S. governmental labor related credits ($200.6 million), non-cash charge related to operating lease right-of-use assets, property and equipment and other assets from disposal by abandonment of certain rental properties ($28.5 million), non-cash charges related to information technology assets ($26.1 million), gain from the insurance proceeds received related to property damage from a tornado in Nashville ($16.3 million gain), charges related to receivables and contractual obligations related to a client ($15.2 million) and a non-cash settlement of a multiemployer pension plan obligation ($6.7 million gain). "Other" for the twelve months ended September 27, 2019 also includes cash compensation charges associated with the retirement of the Company's former chief executive officer ($10.4 million), closing costs mainly related to customer contracts ($8.5 million), duplicate rent charges, moving costs, opening costs to build out and ready the Company's new headquarters while occupying its then existing headquarters and closing costs ($8.2 million), advisory fees related to shareholder matters ($7.7 million), banker fees and other charges related to the sale of Healthcare Technologies ($7.7 million) and settlement charges related to exiting a joint venture arrangement ($4.5 million). | |||||||||||||||||
(6) On April 22, 2020, the Company entered into Amendment No. 9 to the Credit Agreement. Amendment No. 9 provides for a covenant waiver period which suspends the Consolidated Secured Debt Ratio debt covenant required under the credit agreement for four fiscal quarters, commencing with the fourth quarter of fiscal 2020 and ending after the third quarter of fiscal 2021, subject to certain conditions. |
ARAMARK AND SUBSIDIARIES | ||||||||||||||||||||||||||
RECONCILIATION OF NON-GAAP MEASURES | ||||||||||||||||||||||||||
FREE CASH FLOW | ||||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||
Fiscal Year Ended | Nine Months Ended | Three Months Ended | ||||||||||||||||||||||||
October 2, 2020 | September 27, 2019 | June 26, 2020 | October 2, 2020 | |||||||||||||||||||||||
Net Cash provided by (used in) operating activities | $ | 176,682 | $ | 984,227 | $ | (74,845) | $ | 251,527 | ||||||||||||||||||
Net purchases of property and equipment and other | (364,434) | (485,219) | (259,375) | (105,059) | ||||||||||||||||||||||
Free Cash Flow | $ | (187,752) | $ | 499,008 | $ | (334,220) | $ | 146,468 |
ARAMARK AND SUBSIDIARIES | ||||||||||||||||||||||||||||||||
RECONCILIATION OF NON-GAAP MEASURES | ||||||||||||||||||||||||||||||||
ADJUSTED CONSOLIDATED OPERATING (LOSS) INCOME MARGIN | ||||||||||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||||||||||||||
June 26, 2020 | ||||||||||||||||||||||||||||||||
FSS United States | FSS International | Uniform | Corporate | Aramark and Subsidiaries | ||||||||||||||||||||||||||||
Revenue (as reported) | $ | 1,067,580 | $ | 517,171 | $ | 567,502 | $ | 2,152,253 | ||||||||||||||||||||||||
Operating (Loss) Income (as reported) | $ | (193,799) | $ | (138,283) | $ | 21,899 | $ | (17,414) | $ | (327,597) | ||||||||||||||||||||||
Operating (Loss) Income Margin (as reported) | (18.15) | % | (26.74) | % | 3.86 | % | (15.22) | % | ||||||||||||||||||||||||
Revenue (as reported) | $ | 1,067,580 | $ | 517,171 | $ | 567,502 | $ | 2,152,253 | ||||||||||||||||||||||||
Effect of Currency Translation | 534 | 40,188 | 1,377 | 42,099 | ||||||||||||||||||||||||||||
Adjusted Revenue (Organic) | $ | 1,068,114 | $ | 557,359 | $ | 568,879 | $ | 2,194,352 | ||||||||||||||||||||||||
Revenue Growth (as reported) | (55.77) | % | (45.55) | % | (12.34) | % | (46.34) | % | ||||||||||||||||||||||||
Adjusted Revenue Growth (Organic) | (55.74) | % | (41.32) | % | (12.13) | % | (45.29) | % | ||||||||||||||||||||||||
Operating (Loss) Income (as reported) | $ | (193,799) | $ | (138,283) | $ | 21,899 | $ | (17,414) | $ | (327,597) | ||||||||||||||||||||||
Amortization of Acquisition-Related Intangible Assets | 21,246 | 1,661 | 6,266 | — | 29,173 | |||||||||||||||||||||||||||
Severance and Other Charges | 48,205 | 74,704 | 367 | 1,657 | 124,933 | |||||||||||||||||||||||||||
Merger and Integration Related Charges | 169 | 131 | 4,739 | — | 5,039 | |||||||||||||||||||||||||||
Gains, Losses and Settlements impacting comparability | 45,852 | — | (16,348) | (5,205) | 24,299 | |||||||||||||||||||||||||||
Adjusted Operating (Loss) Income | $ | (78,327) | $ | (61,787) | $ | 16,923 | $ | (20,962) | $ | (144,153) | ||||||||||||||||||||||
Effect of Currency Translation | 140 | (4,179) | (161) | — | (4,200) | |||||||||||||||||||||||||||
Adjusted Operating (Loss) Income (Constant Currency) | $ | (78,187) | $ | (65,966) | $ | 16,762 | $ | (20,962) | $ | (148,353) | ||||||||||||||||||||||
Operating (Loss) Income Growth (as reported) | (251.56) | % | (444.36) | % | (59.15) | % | 46.94 | % | (273.50) | % | ||||||||||||||||||||||
Adjusted Operating (Loss) Income Growth | (150.19) | % | (245.01) | % | (74.74) | % | 27.81 | % | (160.92) | % | ||||||||||||||||||||||
Adjusted Operating (Loss) Income Growth (Constant Currency) | (150.10) | % | (254.82) | % | (74.98) | % | 27.81 | % | (162.70) | % | ||||||||||||||||||||||
Adjusted Operating (Loss) Income Margin (Constant Currency) | (7.32) | % | (11.84) | % | 2.95 | % | (6.76) | % | ||||||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||||||||||||||
June 28, 2019 | ||||||||||||||||||||||||||||||||
FSS United States | FSS International | Uniform | Corporate | Aramark and Subsidiaries | ||||||||||||||||||||||||||||
Revenue (as reported) | $ | 2,413,503 | $ | 949,862 | $ | 647,396 | $ | 4,010,761 | ||||||||||||||||||||||||
Operating Income (as reported) | $ | 127,873 | $ | 40,157 | $ | 53,609 | $ | (32,820) | $ | 188,819 | ||||||||||||||||||||||
Amortization of Acquisition-Related Intangible Assets | 21,059 | 1,487 | 6,139 | — | 28,685 | |||||||||||||||||||||||||||
Severance and Other Charges | 642 | — | — | 4,208 | 4,850 | |||||||||||||||||||||||||||
Merger and Integration Related Charges | 2,238 | — | 5,798 | — | 8,036 | |||||||||||||||||||||||||||
Tax Reform Related Employee Reinvestments | 3,627 | — | 1,440 | — | 5,067 | |||||||||||||||||||||||||||
Gains, Losses and Settlements impacting comparability | 615 | 965 | — | (425) | 1,155 | |||||||||||||||||||||||||||
Adjusted Operating Income | $ | 156,054 | $ | 42,609 | $ | 66,986 | $ | (29,037) | $ | 236,612 | ||||||||||||||||||||||
Operating Income Margin (as reported) | 5.30 | % | 4.23 | % | 8.28 | % | 4.71 | % | ||||||||||||||||||||||||
Adjusted Operating Income Margin | 6.47 | % | 4.49 | % | 10.35 | % | 5.90 | % |
ARAMARK AND SUBSIDIARIES | ||||||||||||||||||||||||||||||||
RECONCILIATION OF NON-GAAP MEASURES | ||||||||||||||||||||||||||||||||
ADJUSTED CONSOLIDATED OPERATING INCOME (LOSS) MARGIN | ||||||||||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Nine Months Ended | ||||||||||||||||||||||||||||||||
June 26, 2020 | ||||||||||||||||||||||||||||||||
FSS United States | FSS International | Uniform | Corporate | Aramark and Subsidiaries | ||||||||||||||||||||||||||||
Revenue (as reported) | $ | 5,937,647 | $ | 2,316,813 | $ | 1,882,949 | $ | 10,137,409 | ||||||||||||||||||||||||
Operating Income (Loss) (as reported) | $ | 57,946 | $ | (285,786) | $ | 121,956 | $ | (65,096) | $ | (170,980) | ||||||||||||||||||||||
Operating Income (Loss) Margin (as reported) | 0.98 | % | (12.34) | % | 6.48 | % | (1.69) | % | ||||||||||||||||||||||||
Revenue (as reported) | $ | 5,937,647 | $ | 2,316,813 | $ | 1,882,949 | $ | 10,137,409 | ||||||||||||||||||||||||
Effect of Currency Translation | 651 | 127,817 | 1,681 | 130,149 | ||||||||||||||||||||||||||||
Adjusted Revenue (Organic) | $ | 5,938,298 | $ | 2,444,630 | $ | 1,884,630 | $ | 10,267,558 | ||||||||||||||||||||||||
Revenue Growth (as reported) | (20.73) | % | (18.57) | % | (2.95) | % | (17.42) | % | ||||||||||||||||||||||||
Adjusted Revenue Growth (Organic) | (20.26) | % | (14.07) | % | (2.87) | % | (16.06) | % | ||||||||||||||||||||||||
Operating Income (Loss) (as reported) | $ | 57,946 | $ | (285,786) | $ | 121,956 | $ | (65,096) | $ | (170,980) | ||||||||||||||||||||||
Amortization of Acquisition-Related Intangible Assets | 63,762 | 4,988 | 18,614 | — | 87,364 | |||||||||||||||||||||||||||
Severance and Other Charges | 48,205 | 78,351 | 367 | 4,904 | 131,827 | |||||||||||||||||||||||||||
Merger and Integration Related Charges | 3,480 | 525 | 18,400 | — | 22,405 | |||||||||||||||||||||||||||
Goodwill Impairment | — | 198,600 | — | — | 198,600 | |||||||||||||||||||||||||||
Tax Reform Related Employee Reinvestments | 1,436 | — | (13) | — | 1,423 | |||||||||||||||||||||||||||
Gains, Losses and Settlements impacting comparability | 44,557 | 1,111 | (16,274) | 5,685 | 35,079 | |||||||||||||||||||||||||||
Adjusted Operating Income (Loss) | $ | 219,386 | $ | (2,211) | $ | 143,050 | $ | (54,507) | $ | 305,718 | ||||||||||||||||||||||
Effect of Currency Translation | 74 | (2,592) | (182) | — | (2,700) | |||||||||||||||||||||||||||
Adjusted Operating Income (Loss) (Constant Currency) | $ | 219,460 | $ | (4,803) | $ | 142,868 | $ | (54,507) | $ | 303,018 | ||||||||||||||||||||||
Operating Income (Loss) Growth (as reported) | (89.66) | % | (405.61) | % | (15.60) | % | 42.61 | % | (124.96) | % | ||||||||||||||||||||||
Adjusted Operating Income (Loss) Growth | (59.11) | % | (101.85) | % | (27.52) | % | 37.72 | % | (60.07) | % | ||||||||||||||||||||||
Adjusted Operating Income (Loss) Growth (Constant Currency) | (59.09) | % | (104.03) | % | (27.61) | % | 37.72 | % | (60.42) | % | ||||||||||||||||||||||
Adjusted Operating Income (Loss) Margin (Constant Currency) | 3.70 | % | (0.20) | % | 7.58 | % | 2.95 | % | ||||||||||||||||||||||||
Nine Months Ended | ||||||||||||||||||||||||||||||||
June 28, 2019 | ||||||||||||||||||||||||||||||||
FSS United States | FSS International | Uniform | Corporate | Aramark and Subsidiaries | ||||||||||||||||||||||||||||
Revenue (as reported) | $ | 7,490,818 | $ | 2,845,045 | 1,940,234 | $ | 12,276,097 | |||||||||||||||||||||||||
Effect of Divestitures | (43,680) | — | — | (43,680) | ||||||||||||||||||||||||||||
Adjusted Revenue (Organic) | $ | 7,447,138 | $ | 2,845,045 | $ | 1,940,234 | $ | 12,232,417 | ||||||||||||||||||||||||
Operating Income (as reported) | $ | 560,439 | $ | 93,512 | $ | 144,501 | $ | (113,436) | $ | 685,016 | ||||||||||||||||||||||
Amortization of Acquisition-Related Intangible Assets | 65,487 | 3,975 | 18,273 | — | 87,735 | |||||||||||||||||||||||||||
Severance and Other Charges | 14,589 | 17,945 | 493 | 14,461 | 47,488 | |||||||||||||||||||||||||||
Effect of Divestitures | (4,003) | — | — | — | (4,003) | |||||||||||||||||||||||||||
Merger and Integration Related Charges | 5,520 | — | 20,788 | 8 | 26,316 | |||||||||||||||||||||||||||
Gain on Sale of Healthcare Technologies | (156,309) | — | — | — | (156,309) | |||||||||||||||||||||||||||
Tax Reform Related Employee Reinvestments | 55,429 | 352 | 13,298 | 1,443 | 70,522 | |||||||||||||||||||||||||||
Gains, Losses and Settlements impacting comparability | (4,661) | 3,507 | — | 10,006 | 8,852 | |||||||||||||||||||||||||||
Adjusted Operating Income | $ | 536,491 | $ | 119,291 | $ | 197,353 | $ | (87,518) | $ | 765,617 | ||||||||||||||||||||||
Operating Income Margin (as reported) | 7.48 | % | 3.29 | % | 7.45 | % | 5.58 | % | ||||||||||||||||||||||||
Adjusted Operating Income Margin | 7.20 | % | 4.19 | % | 10.17 | % | 6.26 | % |